The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer.
- DOI
- 10.1038/s41419-026-09162-6
- Published
- 2026 Aug 3
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-09162-6,
title = {The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer.},
author = {Zhao Q and Zou Q and Chu J and Wang Y and Xu T and Dou H and Cai C and Zhang N and Wang F and Gao Y and Cai Y and Liang B and Jin J},
year = {2026},
journal = {Cell death \& disease},
doi = {10.1038/s41419-026-09162-6},
url = {https://doi.org/10.1038/s41419-026-09162-6}
}RIS
TY - JOUR TI - The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer. AU - Zhao Q AU - Zou Q AU - Chu J AU - Wang Y AU - Xu T AU - Dou H AU - Cai C AU - Zhang N AU - Wang F AU - Gao Y AU - Cai Y AU - Liang B AU - Jin J PY - 2026 JO - Cell death & disease DO - 10.1038/s41419-026-09162-6 UR - https://doi.org/10.1038/s41419-026-09162-6 ER -
APA
Q, Z., Q, Z., J, C., Y, W., T, X., H, D., C, C., N, Z., F, W., Y, G., Y, C., B, L., & J, J. (2026). The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer.. Cell death & disease. https://doi.org/10.1038/s41419-026-09162-6
Source records
- pubmed · retrieved 2026-09-26T01:09:47.551Z